Identification of 1H-pyrazolo[3,4-b]pyridines as potential inhibitors of Leishmania arginase

Leishmaniasis, a parasitic disease transmitted by sandflies, remains a significant global health concern, particularly in tropical regions. The arginase enzyme ( La Arg) has emerged as a promising therapeutic target in Leishmania amazonensis . This study employs a computer-aided drug design approach to identify novel La Arg inhibitor candidates. A series of 38 compounds featuring a 1 H -pyrazolo[3,4- b ]pyridine nucleus was evaluated using 3D-QSAR (Py-CoMFA), molecular docking, and molecular dynamics simulations to predict pIC 50 values and investigate molecular interactions within the La Arg active site. Our results identified 14 compounds with promising predicted activity (pIC 50 ≥ 5.00). Molecular docking analysis revealed that 10 compounds establish strong interactions with key catalytic residues (His127 and His142) and Mn 2+ ions, which are crucial for La Arg binding. Molecular dynamics further characterized compounds 1b and 1e as potential arginase inhibitors, though they exhibited distinct thermodynamic profiles. Compound 1b , featuring a nitrile group, demonstrated initial stability and a balanced molecular profile. However, it failed to maintain its binding mode throughout the entire simulation trajectory. Conversely, while 1e remained stable at the site, its bromine substituent incurred a significant solvation penalty, leading to a less favorable binding free energy than 1b . These findings provide significant insights into the structural requirements for arginase inhibition and establish a framework for developing novel therapeutic compounds against leishmaniasis.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-16
DOI
https://doi.org/10.1038/s41598-026-76684-6
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Identification of 1H-pyrazolo[3,4-b]pyridines as potential inhibitors of Leishmania arginase

Joana Lucius de Sousa Ribeiro, Priscila Goes Camargo, Luiza R.S. Dias, Carlos Rangel Rodrigues et al.
Scientific Reports
Computational Drug Discovery Methods
article

Identification of 1H-pyrazolo[3,4-b]pyridines as potential inhibitors of Leishmania arginase

Joana Lucius de Sousa Ribeiro, Priscila Goes Camargo, Luiza R.S. Dias, Carlos Rangel Rodrigues, Magaly Girão Albuquerque, Camilo Henrique da Silva Lima, Júlio César de Araujo Vanelis Soares, Carine Ribeiro dos Santos, Estela M.F. Muri
article en

Abstract

Leishmaniasis, a parasitic disease transmitted by sandflies, remains a significant global health concern, particularly in tropical regions. The arginase enzyme ( La Arg) has emerged as a promising therapeutic target in Leishmania amazonensis . This study employs a computer-aided drug design approach to identify novel La Arg inhibitor candidates. A series of 38 compounds featuring a 1 H -pyrazolo[3,4- b ]pyridine nucleus was evaluated using 3D-QSAR (Py-CoMFA), molecular docking, and molecular dynamics simulations to predict pIC 50 values and investigate molecular interactions within the La Arg active site. Our results identified 14 compounds with promising predicted activity (pIC 50 ≥ 5.00). Molecular docking analysis revealed that 10 compounds establish strong interactions with key catalytic residues (His127 and His142) and Mn 2+ ions, which are crucial for La Arg binding. Molecular dynamics further characterized compounds 1b and 1e as potential arginase inhibitors, though they exhibited distinct thermodynamic profiles. Compound 1b , featuring a nitrile group, demonstrated initial stability and a balanced molecular profile. However, it failed to maintain its binding mode throughout the entire simulation trajectory. Conversely, while 1e remained stable at the site, its bromine substituent incurred a significant solvation penalty, leading to a less favorable binding free energy than 1b . These findings provide significant insights into the structural requirements for arginase inhibition and establish a framework for developing novel therapeutic compounds against leishmaniasis.

Scientific Reports
Universidade Federal do Rio de Janeiro (BR), Universidade Federal Fluminense (BR)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Centro Nacional de Processamento de Alto Desempenho em São Paulo
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon